Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMETI Phase 2: Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index

NCT01701050 is registered in ClinicalTrials.gov with Janssen Diagnostics, LLC as lead sponsor.

NCT NCT01701050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01701050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COMETI Phase 2: Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index
Lead sponsor
Janssen Diagnostics, LLC
Phase
Observational
Overall status
Completed
Start date
April 1, 2013
Completion date
November 10, 2016
Enrollment
121 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer